Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 212, Issue 4, Pages 578-584Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiv089
Keywords
HIV; host genomics; genome-wide association study; immune activation; microbial translocation; sCD14; I-FABP
Categories
Funding
- SHCS - Swiss National Science Foundation [134277, 148522]
- SHCS [617]
- Swiss National Science Foundation [PP00P3_133703]
- Swiss National Science Foundation (SNF) [PP00P3_133703] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Systemic immune activation, a major determinant of human immunodeficiency virus (HIV) disease progression, is the result of a complex interplay between viral replication, dysregulation of the immune system, and microbial translocation due to gut mucosal damage. Although human genetic variants influencing HIV load have been identified, it is unknown how much the host genetic background contributes to interindividual differences in other determinants of HIV pathogenesis such as gut damage and microbial translocation. Using samples and data from 717 untreated participants in the Swiss HIV Cohort Study and a genome-wide association study design, we searched for human genetic determinants of plasma levels of intestinal fatty acid-binding protein (I-FABP/FABP2), a marker of gut damage, and of soluble CD14 (sCD14), a marker of lipopolysaccharide bioactivity and microbial translocation. We also assessed the correlations between HIV load, sCD14, and I-FABP. Although we found no genome-wide significant determinant of the tested plasma markers, we observed strong associations between sCD14 and both HIV load and I-FABP, shedding new light on the relationships between processes that drive progression of untreated HIV infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available